fda covid - Search News

Order byBest matchMost fresh

FDA, COVID and Vaccinations

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 lineage, with a preference for the LP.8.1 variant.

· 1h

· 8h · on MSN

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

Scientific American · 12h

What FDA’s Planned Limits on COVID Vaccinations Mean for Health

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 17h

· 2d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

STAT · 10h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

11hon MSN

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership,

1don MSN

Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat